Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06509009
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-05-23
Brief Title:
Nimotuzumab Combined With TGP as First-line Therapy in Patients With RecurrentMetastatic Nasopharyngeal Carcinoma
Sponsor:
Organization:
None